title: The expression and synthesis of the band 3 protein initiates the formation of a stable membrane skeleton in murine Rauscher-transformed erythroid cells.
abstract: While the temporal sequences of the synthesis and assembly of membrane skeletal proteins has been studied during erythroid maturation, relatively little is known about the events which initiate the assembly of membrane skeleton at the early stages of mammalian erythroid commitment. To investigate the early events that initiate the assembly of the membrane skeleton in mammalian erythroid cells, we have studied the synthesis and assembly of membrane skeletal proteins in murine Rauscher erythroleukemia virus-transformed cells. These cells are blocked in differentiation at around the early progenitor (burst forming unit-erythroid, BFUe) cell stage but can be induced to differentiate in vitro. Pulse-labeling studies reveal that Rauscher cells actively synthesize alpha spectrin, beta spectrin, ankyrin and band 4.1 proteins. However, the synthesis of the band 3 protein and its mRNA are barely detectable in these cells. The peripheral membrane skeletal components assemble only transiently in the membrane skeleton and turn over rapidly, resulting in about 20-fold lower steady state levels than are found in mature erythrocytes. Upon induction with erythropoietin and dimethyl sulfoxide, the mRNA level and synthesis of band 3 are increased about 50-fold. In contrast, the synthesis of spectrin, ankyrin and band 4.1 is increased only about 1.5 to 2.0-fold. However, after induction, the fraction of these proteins assembled on the membrane is increased, their half-lives on the membrane are nearly doubled with a concomitant 4 to 5-fold increase in their steady-state levels. These results suggest that the synthesis of peripheral membrane proteins is detected at the earliest stages of erythroid commitment and increases only slightly during further differentiation.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Biomedical Research, St. Elizabeth's Hospital, Tufts University School of Medicine, Boston, MA 02135.
authors.forename: M
authors.initials: M
authors.lastname: Hanspal
authors.forename: J S
authors.initials: JS
authors.lastname: Hanspal
authors.forename: R
authors.initials: R
authors.lastname: Kalraiya
authors.forename: J
authors.initials: J
authors.lastname: Palek
mesh_terms: D000818:Animals; D001457:Anion Exchange Protein 1, Erythrocyte / Q000096:biosynthesis*; D017487:Ankyrins / Q000096:biosynthesis; D003598:Cytoskeletal Proteins; D003599:Cytoskeleton / Q000378:metabolism; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000378:metabolism*; D004920:Erythropoiesis; D008565:Membrane Proteins / Q000096:biosynthesis; D051379:Mice; D009479:Neuropeptides; D012333:RNA, Messenger / Q000032:analysis; D013049:Spectrin / Q000096:biosynthesis; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D001457:Anion Exchange Protein 1, Erythrocyte; D017487:Ankyrins; D003598:Cytoskeletal Proteins; D008565:Membrane Proteins; D009479:Neuropeptides; D012333:RNA, Messenger; C028841:erythrocyte membrane band 4.1 protein; C120557:erythrocyte membrane protein band 4.1-like 1; D013049:Spectrin; D004121:Dimethyl Sulfoxide